1. Estrogen-responsive protein Efp controls cell cycle and breast tumors growth

Table S3. List of 103 probes and their corresponding Entrez gene ids and Symbols. Those probes were selected as predictive of breast cancer progression to metastasis.

Table S4. The 30 best predictive genes for progression to metastasis prognosis as ranked by the gene predictive index. The top eight genes constitute the best predictor. The genes highlighted in bold are among the original 70-gene signature set.

Table S1.  List of the most predictive genes. The first 5 genes are the best predictors of gene expression profiles of whole blood samples from rheumatoid arthritis patients who responded to TNF-blockade treatment with adalimumab  etanercept  or infliximab

Table S6. The 46 best predictive genes for classifying ALL vesus AML Leukemia as ranked by the gene predictive index. The top eight genes constitute the best predictor.

Table S5. The 80 probes selected as predictive of the ALL or AML subtype of Table S5. The 80 probes selected as predictive of the ALL or AML subtype of Leukemia.

Table S8. The 16 best predictive genes for classifying prostate tumor versus normal prostate tissue as ranked by the gene predictive index. The top five genes constitute the best predictor.

Table S7. The 79 probes selected as predictive of the tumor ves normal tissue in Prostate Cancer set.

SuppTable 1. Genes differentially expressed between Hunk-wild type and Hunk-deficient c-myc-induced mouse mammary tumors

SuppFigure 4: Supervised two-dimensional hierarchical clustering based on average linkage uncentered correlation of emphysema samples using microarray expression data of the 51 genes represented in Spira and Golpon platforms

SuppTable 2: Genes differentially expressed between mild and moderate emphysema patients

Table 2. GO analysis of differentially expressed genes on PTHrP ablation in MMTV-neu tumors

12 Genes used for breast cancer molecular subtype assignment

Table III. Genes less expressed in post-chemotherapy samples (pFDR <0.01 and Fc ò2).